- Home
- WETH vs SNTI Comparison
WETH vs SNTI Comparison
Compare WETH & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETH
- SNTI
- Stock Information
- Founded
- WETH 1992
- SNTI 2016
- Country
- WETH China
- SNTI United States
- Employees
- WETH N/A
- SNTI N/A
- Industry
- WETH
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- WETH
- SNTI Health Care
- Exchange
- WETH Nasdaq
- SNTI Nasdaq
- Market Cap
- WETH 21.5M
- SNTI 21.4M
- IPO Year
- WETH N/A
- SNTI N/A
- Fundamental
- Price
- WETH $1.60
- SNTI $4.57
- Analyst Decision
- WETH
- SNTI Strong Buy
- Analyst Count
- WETH 0
- SNTI 1
- Target Price
- WETH N/A
- SNTI $12.00
- AVG Volume (30 Days)
- WETH 400.5K
- SNTI 98.1K
- Earning Date
- WETH 02-17-2025
- SNTI 03-20-2025
- Dividend Yield
- WETH N/A
- SNTI N/A
- EPS Growth
- WETH N/A
- SNTI N/A
- EPS
- WETH 0.34
- SNTI N/A
- Revenue
- WETH $41,024,264.00
- SNTI N/A
- Revenue This Year
- WETH N/A
- SNTI $11.52
- Revenue Next Year
- WETH N/A
- SNTI $78.57
- P/E Ratio
- WETH $4.69
- SNTI N/A
- Revenue Growth
- WETH 2.86
- SNTI N/A
- 52 Week Low
- WETH $1.13
- SNTI $1.52
- 52 Week High
- WETH $5.70
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- WETH 45.57
- SNTI 55.11
- Support Level
- WETH $1.48
- SNTI $3.72
- Resistance Level
- WETH $2.00
- SNTI $4.93
- Average True Range (ATR)
- WETH 0.16
- SNTI 0.46
- MACD
- WETH -0.01
- SNTI 0.04
- Stochastic Oscillator
- WETH 22.12
- SNTI 74.83
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.